How to Buy Immunoprecise Antibodies Stock
Immunoprecise Antibodies Ltd
ImmunoPrecise Antibodies Ltd. , together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally.
Immunoprecise Antibodies stock last closed at $2.37, down 4.82% from the previous day, and has increased 209.8% in one year. It has overperformed other stocks in the Biotechnology industry by 2.63 percentage points. Immunoprecise Antibodies stock is currently +777.78% from its 52-week low of $0.27, and -26.99% from its 52-week high of $3.25.
At the moment, there are 46.15M IPA shares outstanding. The market value of IPA is $109.39M. In the past 24 hours, 1.39M IPA shares were traded.
How to Buy Immunoprecise Antibodies Stock
Not sure how to invest in Immunoprecise Antibodies stock? Here's how.
- Choose where to buy Immunoprecise Antibodies stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Immunoprecise Antibodies stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your payment method and add your information.
- Analyze Immunoprecise Antibodies stock: The Immunoprecise Antibodies ticker symbol is IPA. Is Immunoprecise Antibodies stock a good investment? Should you buy shares of IPA? How do IPA's underlying business fundamentals look? Do top analysts think Immunoprecise Antibodies is a good buy? Why has IPA's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if IPA is a good stock to buy).
- Execute your IPA trade: Decide if you will purchase IPA shares at the current market price or use a limit order to purchase IPA shares at a particular price.
- Get the latest news on your investment in IPA: Create a watchlist to keep tabs on your new investment in Immunoprecise Antibodies stock.
Step 1: Choose where to buy Immunoprecise Antibodies stock
You need a brokerage account to access the NASDAQ market and buy IPA shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to invest in IPA today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing money into your brokerage account.
Step 4: Analyze Immunoprecise Antibodies stock
After you have figured out the best place to buy Immunoprecise Antibodies stock, it's critical to analyze their stock prior to investing, so you can comprehend the risk as well as the opportunity.
Immunoprecise Antibodies stock quick numbers
IPA Due Diligence Checks
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on IPA's stock page.
How is IPA stock valued?
You can use many financial metrics, analyses, models, and charts to gauge IPA's fair value.
Using relative valuations measures:
- IPA may be overvalued based on its P/B ratio of 6.34x, relative to Biotechnology industry P/B ratio of 4.56x
You can do more valuation research on IPA's stock here.
Is IPA a healthy company?
Pros:
- IPA has cash burn of 5262043. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the IPA balance sheet.
- There are more short-term assets than short-term liabilities on the IPA balance sheet.
- IPA has $7.88M in cash and short term investments. This is sufficient to cover its annual cash burn of $5.26M.
Cons:
- Total IPA debt is higher than 5 years ago, relative to shareholder equity.
- IPA has a relatively high debt to equity ratio of 0.88.
- IPA profit margin has gone down from -106.5% to -123.3% in the past year.
Is it a good time to buy Immunoprecise Antibodies stock, according to Wall Street analysts?
Out of 2 Equities analysts who give forecasts on IPA, the consensus analyst rating on Immunoprecise Antibodies is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Immunoprecise Antibodies stock forecast page.
Metrics for Advanced IPA Traders
IPA Performance Metrics
Last year, IPA revenue was $17.90M. In the past 5 year, IPA's revenue has gone up by 12.25% per year. This was slower than the Biotechnology industry average of 67.2%.
You can research IPA's earnings and revenue performance here.
Are IPA insiders buying or selling the stock?
In the last year, executives and large shareholders at IPA have not bought or sold any shares.
Get more info about who owns IPA shares here.
Can I get consistent income from IPA stock?
No, Immunoprecise Antibodies doesn't provide an income stream by paying out dividends.
What others are saying about IPA
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your IPA trade
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, place a limit order.
Press the Open button and your broker will execute your order.
If you want additional info about buying stocks on eToro, click the how to video below:
Step 6: Get the latest news on your investment in IPA
Now that you own some IPA shares, you'll want to keep up with your new company.
Start a watchlist to get notified of important updates regarding your IPA stock.
IPA Feed
How to Buy Stock in Immunoprecise Antibodies
To summarize, here are the 6 steps for buying Immunoprecise Antibodies stock:
- Choose where to buy Immunoprecise Antibodies stock
- Sign up for your brokerage account
- Put funds into your brokerage account
- Analyze Immunoprecise Antibodies stock
- Execute your IPA trade
- Get the latest news on your investment in IPA
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Immunoprecise Antibodies, get started below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.